Investors seeking alternatives to AI-heavy portfolios are finding value in DVA, BEN, and ADM, as each company leverages unique industry tailwinds to drive significant year-to-date gains.
DaVita's dialysis business benefits from improved reimbursement rates and cost discipline, with reaffirmed bullish guidance and analyst upside.
Franklin Resources beat earnings estimates and moderated outflows, with revenue growth and acquisitions supporting continued gains.
Archer Daniels Midland raised full-year adjusted EPS guidance after strong execution and recovering grain processing volumes, though analysts remain cautious.
DaVita, Franklin Resources, and Archer Daniels Midland have outperformed the broader market in 2026, each posting gains exceeding 30% year-to-date. These companies demonstrate strong operational fundamentals and sector-specific catalysts that operate independently of the current AI-driven market cycle, offering investors a viable path for portfolio diversification.
These companies rely on sector-specific drivers such as healthcare demand for DaVita, asset management performance for Franklin Resources, and agricultural commodity processing for ADM, rather than speculative technology trends.